SOTYLIZE

Peak

sotalol hydrochloride

R-Pharm US
NDAORALSOLUTION
Approved
Oct 2014
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Aug 31, 2035
115 months away
Patent Expiry
Aug 31, 2035

Patent Records (5)

Patent #ExpiryTypeUse Code
10206895
Apr 1, 2034
Product
U-2494
11013703
Apr 1, 2034
Product
—
12290495
Apr 1, 2034
U-2494
11850222
Nov 19, 2034
U-2494
9724297
Aug 31, 2035
Product
U-2096
Company
R-Pharm US
R-Pharm US
NJ - Princeton
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers